Status:
UNKNOWN
Dengue Serostatus Study in the Philippines
Lead Sponsor:
University of the Philippines
Collaborating Sponsors:
Department of Health, Philippines
World Health Organization
Conditions:
Dengue
Severe Dengue
Eligibility:
All Genders
9-14 years
Brief Summary
This is an observational study for 5 years, and aims to determine the risk of developing dengue among Philippine children who are eligible to receive the dengue vaccine during the DOH mass dengue vacc...
Detailed Description
This is a cohort study that aims to determine the relative risk of developing virologically-confirmed dengue among Philippine children who are eligible to receive dengue vaccine during the DOH Mass De...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Provide signed informed consent and assent (as applicable)
- Be a child belonging to the specified age group and resident of the targeted communities of the DOH dengue mass immunization
- Be eligible to receive dengue vaccine during the DOH dengue mass immunization in 2017
- Exclusion criteria:
- Any subject whose parent/guardian refuse to provide informed consent and/or assent
- Children who do not belong to the specified age groups and not residents of the targeted communities
- Children \<9 years old
- Children with history of bleeding disorder
- Any subject previously enrolled in a dengue vaccine clinical trial
Exclusion
Key Trial Info
Start Date :
November 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
2996 Patients enrolled
Trial Details
Trial ID
NCT03465254
Start Date
November 1 2016
End Date
June 1 2023
Last Update
May 17 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.